Applications from the field of Pharma & Biopharma focused on ICP/MS | LabRulez ICPMS

Proposed new ICH and USP methods for elemental impurities: The application of ICP-MS and ICP-OES for pharmaceutical analysis

Technical notes

| 2014 | Agilent Technologies

ICP/MS, ICP/OES

Instrumentation

ICP/MS, ICP/OES

Manufacturer

Agilent Technologies

Industries

Pharma & Biopharma

WCPS: Validating ICP-MS Using USP<232>/<233> for Elemental Impurity Analysis in Pharmaceutical Products

Posters

| 2012 | Agilent Technologies

ICP/MS

Instrumentation

ICP/MS

Manufacturer

Agilent Technologies

Industries

Pharma & Biopharma

Agilent ICP-MS Journal (February 2010 – Issue 41)

Others

| 2010 | Agilent Technologies

ICP/MS

Instrumentation

ICP/MS

Manufacturer

Agilent Technologies

Industries

Pharma & Biopharma, Clinical Research

Validating performance of an Agilent ICP‑MS for USP <232>/<233> & ICH Q3D(R2)/Q2(R1)

Applications

| 2022 | Agilent Technologies

ICP/MS

Instrumentation

ICP/MS

Manufacturer

Agilent Technologies

Industries

Pharma & Biopharma

Analysis of Toxic Elements in Supplements as per USP 2232 Using the ICPMS-2030

Applications

| 2016 | Shimadzu

ICP/MS

Instrumentation

ICP/MS

Manufacturer

Shimadzu

Industries

Pharma & Biopharma

ICP-MS ELEMENTAL IMPURITY ANALYSIS IN PHARMACEUTICALS

Others

| 2017 | Agilent Technologies

ICP/MS

Instrumentation

ICP/MS

Manufacturer

Agilent Technologies

Industries

Pharma & Biopharma

Alternative sample preparation and analysis approach for ICH/USP controlled metals by ICP-MS

Posters

| N/A | Agilent Technologies

ICP/MS

Instrumentation

ICP/MS

Manufacturer

Agilent Technologies

Industries

Pharma & Biopharma

WCPS: Single-Cell and Bulk ICP-MS Investigation of Accumulation Patterns of Pt-based Drugs in Cisplatin–Sensitive and –Resistant Cell Models

Posters

| 2023 | Agilent Technologies

ICP/MS, ICP/MS/MS

Instrumentation

ICP/MS, ICP/MS/MS

Manufacturer

Agilent Technologies

Industries

Pharma & Biopharma, Clinical Research

Agilent ICP-MS Journal (August 2011 – Issue 47)

Others

| 2011 | Agilent Technologies

ICP/MS, Speciation analysis

Instrumentation

ICP/MS, Speciation analysis

Manufacturer

Agilent Technologies

Industries

Environmental, Pharma & Biopharma

A novel ICP-MS/MS approach for the analysis of vanadium in glucose magnesium sulfate injection to meet the requirement of USP<232>/<233>

Posters

| 2019 | Agilent Technologies (ASMS)

ICP/MS, ICP/MS/MS

Instrumentation

ICP/MS, ICP/MS/MS

Manufacturer

Agilent Technologies

Industries

Pharma & Biopharma

Applications from the field of Pharma & Biopharma focused on ICP/MS | LabRulez ICPMS

Proposed new ICH and USP methods for elemental impurities: The application of ICP-MS and ICP-OES for pharmaceutical analysis

WCPS: Validating ICP-MS Using USP<232>/<233> for Elemental Impurity Analysis in Pharmaceutical Products

Agilent ICP-MS Journal (February 2010 – Issue 41)

Validating performance of an Agilent ICP‑MS for USP <232>/<233> & ICH Q3D(R2)/Q2(R1)

Analysis of Toxic Elements in Supplements as per USP 2232 Using the ICPMS-2030

ICP-MS ELEMENTAL IMPURITY ANALYSIS IN PHARMACEUTICALS

Alternative sample preparation and analysis approach for ICH/USP controlled metals by ICP-MS

WCPS: Single-Cell and Bulk ICP-MS Investigation of Accumulation Patterns of Pt-based Drugs in Cisplatin–Sensitive and –Resistant Cell Models

Agilent ICP-MS Journal (August 2011 – Issue 47)

A novel ICP-MS/MS approach for the analysis of vanadium in glucose magnesium sulfate injection to meet the requirement of USP<232>/<233>

Related content

From a scientific project to a global business venture. The company mzio is striving to improve data analysis in mass spectrometry labs

Cryo-EM structures show how Trypanosomes escape the human innate immune response

An innovative approach to planar chiral substances